help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2008-2662
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Google Scholar
Right arrow Articles by Gläser, S.
Right arrow Articles by Koch, B.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gläser, S.
Right arrow Articles by Koch, B.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Related Collections
Right arrow Metabolism
The Journal of Clinical Endocrinology & Metabolism Vol. 94, No. 7 2452-2458
Copyright © 2009 by The Endocrine Society

Association between Serum Insulin-Like Growth Factor (IGF) I and IGF Binding Protein-3 and Lung Function

Sven Gläser1, Nele Friedrich1, Ralf Ewert, Christoph Schäper, Matthias Nauck, Marcus Dörr, Henry Völzke, Stephan B. Felix, Alexander Krebs, Henri Wallaschofski1 and Beate Koch1

Department of Internal Medicine B, Pulmonary Medicine and Infectious Diseases (S.G., R.E., C.S., B.K.); Institute of Clinical Chemistry and Laboratory Medicine (N.F., M.N., A.K., H.W.); Department of Internal Medicine B–Cardiology (M.D., S.B.F.); and Institute for Community Medicine (H.V.), Ernst-Moritz-Arndt University Greifswald, D-17475 Greifswald, Germany

Address all correspondence and requests for reprints to: Sven Gläser, M.D., Medical Faculty of the Ernst-Moritz-Arndt University, Department of Internal Medicine B—Pulmonary Medicine and Infectious Diseases, University Hospital Ferdinand-Sauerbruchstrasse, D-17475 Greifswald, Germany. E-mail: glaeser.sven{at}gmail.com.

Background: There is strong evidence that IGF-I and IGF binding protein 3 (IGFBP-3), as central mediators of endocrine and finally metabolic or anabolic effects of GH, were associated with increased lung size in acromegaly or a decrease of respiratory muscle pressures in patients with GH deficiency. The aim of the present study was to further clarify the impact of IGF-I and IGFBP-3 levels on lung volumes and respiratory pressures in a general adult population.

Material and Methods: From the Study of Health in Pomerania, 1326 subjects aged 25 to 85 yr participated in standardized pulmonary function testing. IGF-I and IGFBP-3 levels were measured with the Immulite 2500 system. Multivariable linear regression analyses adjusted for age, sex, body mass index, physical activity, and smoking were performed.

Results: In men, positive linear associations between IGF-I and IGF-I/IGFBP-3 ratio with forced expiratory volume in 1 sec (FEV1) as well as with forced vital capacity (FVC) were detected across all ages, whereas in women this positive association was only detectable above 50 yr. Furthermore, the analyses indicated positive linear relations of IGF-I/IGFBP-3 ratio with FEV1 and FVC, respectively. No significant relations between IGF-I or IGFBP-3 and maximal inspiratory pressure was detectable in both sexes.

Conclusion: In conclusion, higher IGF-I levels were associated with higher lung volumes in men, whereas in women this association was only detectable in subjects older than 50 yr. Higher IGF-I values were not associated with increased respiratory muscle strength measured as maximal inspiratory pressure.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2009 by The Endocrine Society